3rd generation glp 1 agonist Frontiers LY3437943, a novel triple glucagon,

Saxenda is a 3 mg subcutaneous injection to be used daily 1x in the abdomen, thigh, or arm

Under normal physiological conditions, however, GLP-1 is rapidly degraded by the enzyme dipeptidyl peptidase IV (DPP-4), giving it a fleeting half-life of just a few minutes

Individuals should always consult their healthcare provider before starting any new dietary supplement

[40] [41] Heymsfield, S

The fraction of weight lost as fat-free mass depends on baseline adiposity, age, sex, diet, protein intake, inactivity, resistance training, metabolic state, and the rate and duration of weight loss

Modulation of the inflammatory response, helping prevent liver fibrosis (Vachliotis and Polyzos 2023)